3D-Matrix holds a license from MIT for the production of PuraMatrixTM, a hydrogel composed of repeating units of arg-ala-asp-ala in aqueous solution. The peptide self-assembles into nanofibers on a scale similar to the extracellular matrix when exposed to physiological salt concentrations, forming a flowable hydrogel. 3D-Matrix reports to have taken another license from MIT which is directed to a modified surfactant-like self-assembling peptide which activates biological functions by a short motif sequence peptide. 3D matrix will apply this peptide to cell culture and regenerative medicine.
3D-Matrix press release, Jan. 27, 2015